A5026067658- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Pulmonary Hypertension Research and Treatments
- Heart Failure Treatment and Management
- Cardiac Arrest and Resuscitation
- Cardiac pacing and defibrillation studies
- Transplantation: Methods and Outcomes
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
- Cardiovascular and exercise physiology
- Venous Thromboembolism Diagnosis and Management
- Nutrition and Health in Aging
- Hemodynamic Monitoring and Therapy
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiovascular Issues in Pregnancy
- Liver Disease and Transplantation
- Organ Transplantation Techniques and Outcomes
- Healthcare Systems and Practices
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Renal Transplantation Outcomes and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
- Cardiac Health and Mental Health
- Cardiac Imaging and Diagnostics
Michigan Medicine
2017-2025
University of Michigan
2016-2025
Michigan United
2024
Hanoi Open University
2024
International Society for Heart and Lung Transplantation
2024
IFC Research (United Kingdom)
2024
Leiden University Medical Center
2023
Medizinische Hochschule Hannover
2023
University Hospital of Wales
2023
Mallinckrodt (United States)
2023
Section:ChooseTop of pageAbstract <<Summary Recommendation...IntroductionMethodsResultsDiscussionConclusionsAuthors’ NoteReferences
Atrial arrhythmias, including atrial fibrillation and flutter, are common in patients with pulmonary hypertension closely associated clinical decompensation poor outcomes. The mechanisms of arrhythmogenesis subsequent reviewed. Practical implications current evidence for the management arrhythmias summarised.
Background: Racial disparities in access to advanced therapies for heart failure (HF) patients are well documented, although the reasons remain uncertain. We sought determine association of race on utilization ventricular assist device (VAD) and transplant among with care at VAD centers if patient preferences impact effect. Methods: performed an observational cohort study ambulatory chronic systolic HF high-risk features no contraindication enrolled 21 followed 2 years REVIVAL (Registry...
While left ventricular assist devices (LVADs) increase survival for patients with advanced heart failure (HF), racial and sex access outcome inequities remain are poorly understood.To assess risk-adjusted in outcomes both Black female to examine heterogeneity treatment decisions among whom clinician discretion has a more prominent role.This retrospective cohort study of 12 310 Medicare beneficiaries used 100% Fee-for-Service administrative claims. Included had been admitted from 2008 2014....
There is a need to better assess the cumulative effect on morbidity and mortality in patients undergoing durable left ventricular assist device (LVAD) implantation. This study evaluates patient-centered performance metric (days alive out of hospital [DAOH]) for LVAD therapy.
Patients with heart failure (HF) overestimate survival compared model-predicted estimates, but the reasons for this discrepancy are poorly understood. We characterized how patients end-stage HF and their care partners understand prognosis elicited preferences around communication.
Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic (CTEPH) have low levels of physical activity (PA). Increased PA has health benefits including improved quality life. This study aimed to identify patient-perceived barriers that correlate objectively measured in this population. We performed a cross-sectional survey 40 patients PAH CTEPH. Participants rated how often 15 interfere being physically active on 5-point Likert Scale. The primary outcome measure was...